Alkem Laboratories says USFDA inspection at Taloja facility ends with 'zero' observations

FPJ Web DeskUpdated: Thursday, July 29, 2021, 02:17 PM IST
article-image
A form 483 is issued by the USFDA to notify a company's management of any objectionable condition at its manufacturing facility |

Drug firm Alkem Laboratories on Thursday said the US health regulator has conducted an inspection of its Taloja facility in Maharashtra, and it ended with 'zero' observations.

The US Food and Drug Administration (USFDA) had conducted a remote and virtual bio-analytical inspection of the company's Bioequivalence Center located at Taloja, Maharashtra from July 26-28, 2021, Alkem Laboratories said in a regulatory filing.

At the end of the inspection, no form 483 was issued, the company added.

A form 483 is issued by the USFDA to notify a company's management of any objectionable condition at its manufacturing facility. The form is issued after completing the inspection.

Shares of Alkem Laboratories were trading 0.30 per cent lower at Rs 3,362.05 apiece on BSE.

(If you have a story in and around Mumbai, you have our ears, be a citizen journalist and send us your story here. )

(To receive our E-paper on WhatsApp daily, please click here.  To receive it on Telegram, please click here. We permit sharing of the paper's PDF on WhatsApp and other social media platforms.)

RECENT STORIES

Indian traders accuse Samsung of anti-competitive practices, write to CCI

Indian traders accuse Samsung of anti-competitive practices, write to CCI

India's CAG calls AI game changer for public audit

India's CAG calls AI game changer for public audit

Tata, MG dragged back as EV sales drop by 10% in India

Tata, MG dragged back as EV sales drop by 10% in India

GVK Vice Chairman denies Rahul Gandhi's claims about pressure to sell Mumbai airport to Adani

GVK Vice Chairman denies Rahul Gandhi's claims about pressure to sell Mumbai airport to Adani

Axis Bank allots 2,80,256 shares as stock options for employees

Axis Bank allots 2,80,256 shares as stock options for employees